The findings of this research have the potential to be integrated into standard clinical practice, particularly when combined with clinical and biochemical data from other modalities to increase accuracy, enabling easier identification of at‐risk individuals and facilitating the development of tailored interventions for PNPLA3 I148M‐associated liver disease. This evidence concerns the gene PNPLA3 and liver disorder.